Caligan Partners LP 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Caligan Partners LP disclosed 16 US equity positions worth $479.2m in its Q1 2025 13F filing. The largest position was LQDA at 25.0% of the reported book, followed by VRNA and EXEL. Against the Q4 2024 filing, it opened 3 new positions, added to 8 and reduced 0 among the top 16 holdings.
What did Caligan Partners LP own in Q1 2025? Top 16 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | LQDA LIQUIDIA CORPORATION | Healthcare | 25.0% | $119.7m | 8,118,592 | 0% | held |
| 2 | VRNA VERONA PHARMA PLC | 19.0% | $91.2m | 1,436,878 | 0% | held | |
| 3 | EXEL EXELIXIS INC | Healthcare | 11.8% | $56.3m | 1,525,730 | 0% | held |
| 4 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 7.1% | $34.1m | 2,149,667 | 113% | added |
| 5 | EOLS EVOLUS INC | Healthcare | 6.9% | $32.9m | 2,731,154 | 1% | added |
| 6 | SG7 SAGE THERAPEUTICS INC | 5.1% | $24.3m | 3,052,538 | 0% | held | |
| 7 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 4.9% | $23.3m | 3,107,669 | 4% | added |
| 8 | ANIK ANIKA THERAPEUTICS INC | Healthcare | 4.5% | $21.6m | 1,435,130 | 0% | held |
| 9 | AGIO AGIOS PHARMACEUTICALS INC | Healthcare | 4.3% | $20.5m | 701,280 | 12% | added |
| 10 | RVMD REVOLUTION MEDICINES INC | Healthcare | 3.4% | $16.4m | 465,000 | – | new |
| 11 | MERUS N V | 3.3% | $15.9m | 376,954 | 48% | added | |
| 12 | YMABUSD Y-MABS THERAPEUTICS INC | 2.2% | $10.4m | 2,342,609 | 33% | added | |
| 13 | ABVX ABIVAX SA | 1.7% | $7.9m | 1,269,119 | 69% | added | |
| 14 | VRCA VERRICA PHARMACEUTICALS INC | 0.8% | $4.0m | 8,992,954 | 21% | added | |
| 15 | RZLT REZOLUTE INC | 0.1% | $409.8k | 141,309 | – | new | |
| 16 | TYRA TYRA BIOSCIENCES INC | Healthcare | 0.0% | $232.5k | 25,000 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.